Tender Results of The Common Services Agency More Commonly Known As Nhs National Services Scotland Nss

NP93923a Dimethyl Fumarate (Skilarence®)-The scope of this framework is to supply Dimethyl Fumarate (Skilarence®) in secondary and homecare settings. The tender covers: Dimethyl Fumarate 30mg Gastro-resistant Tablets, 42pk, Dimethyl Fumarate 120mg Gastro-resistant Tablets, 90pk & Dimethyl Fumarate 120mg Gastro-resistant Tablets, 180pk.

ERT Medicines-Supply of ERT medicines to NHS Scotland: NP92615 (a) Laronidase - Aldurazyme® NP92615 (b) Imiglucerase - Cerezyme® NP92615 (c) Agalsidase Beta - Fabrazyme® NP92615 (d) Alglucosidase Alfa - Myozyme® Total value of the procurement (II.1.7) covers the total fifteen (15) month period, three (3) months which are covered in line with Regulation 72(1)(a) of the Public Contracts (Scotland) Regulations 2015. Total value of the concession/lot (V2.4) covers the twelve (12) month extension period as cove...

ERT Medicines-Total value of the procurement (II.1.7) covers the total fifteen (15) month period, three (3) months which are covered in line with Regulation 72(1)(a) of the Public Contracts (Scotland) Regulations 2015. Total value of the concession/lot (V2.4) covers the twelve (12) month extension period as covered in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015. OJEU notice numbers for each of the individual Awards: NP92619(a)Aldurazyme®- 2019/S 170-415123 NP92619...

NP93923a Dimethyl Fumarate (Skilarence®)-The estimated values referred to in Section II.I.7 and V.2.4 cover the full fifty (50) month contract duration. (SC Ref:732706) Supply of Dimethyl Fumarate (Skilarence®) to NHS Scotland. The Authority has awarded this Framework Agreement as a Single Supplier Framework per line in secondary and homecare settings.

ERT Medicines-Supply of ERT medicines to NHS Scotland: NP92617 (e) Velaglucerase alfa - VPRIV® NP92617 (f) Idursulfase - Elaprase® NP92617 (g) Agalsidase Alfa - Replagal® Total value of the procurement (II.1.7) covers the total fifteen (15) month period, three (3) months which are covered in line with Regulation 72(1)(a) of the Public Contracts (Scotland) Regulations 2015. Total value of the concession/lot (V2.4) covers the twelve (12) month extension period as covered in line with Regulation 72(1)(c) of ...

NP93923a Dimethyl Fumarate (Skilarence®)-Supply of Dimethyl Fumarate (Skilarence®) to NHS Scotland. The Authority has awarded this Framework Agreement as a Single Supplier Framework per line in secondary and homecare settings. The estimated values referred to in Section II.I.7 and V.2.4 cover the full fifty (50) month contract duration. (SC Ref:732706)

ERT Medicines-Total value of the procurement (II.1.7) covers the total fifteen (15) month period, three (3) months which are covered in line with Regulation 72(1)(a) of the Public Contracts (Scotland) Regulations 2015. Total value of the concession/lot (V2.4) covers the twelve (12) month extension period as covered in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015. OJEU notice numbers for each of the individual Awards: NP92619(e)VPRIV®- 2019/S 170-415137 NP92619(...

NP93823b Cell-based Quadrivalent Influenza Vaccine-This procurement is for the supply of cell-based quadrivalent influenza vaccine for use in the NHS Scotland 2023/24 Seasonal Flu Programme.

NP93823a Adjuvanted Quadrivalent Influenza Vaccine-This procurement is for the supply of adjuvanted quadrivalent influenza vaccine for use in the NHS Scotland Seasonal Flu Programme.

NP93823b Cell-based Quadrivalent Influenza Vaccine-This procurement is for the supply of cell-based quadrivalent influenza vaccine for use in the NHS Scotland 2023/24 Seasonal Flu Programme The estimated values referred to in Section II.I.7 and V.2.4 cover the full twelve (12) month contract duration. (SC Ref:730489)